BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 33517164)

  • 1. ZMYND8 promotes the growth and metastasis of hepatocellular carcinoma by promoting HK2-mediated glycolysis.
    Dou C; Mo H; Chen T; Liu J; Zeng Y; Li S; Guo C; Zhang C
    Pathol Res Pract; 2021 Mar; 219():153345. PubMed ID: 33517164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma.
    Choi S; Lee KW; Koh HH; Park S; Yeo SY; Joh JW; Choi MS; Kim SH; Park CK; Ha SY
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3517-3534. PubMed ID: 34462784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSN5 upregulates glycolysis to promote hepatocellular carcinoma metastasis via stabilizing the HK2 protein.
    Huang M; Xiong H; Luo D; Xu B; Liu H
    Exp Cell Res; 2020 Mar; 388(2):111876. PubMed ID: 31991125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
    Ding Z; Guo L; Deng Z; Li P
    Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway.
    Dou C; Sun L; Wang L; Cheng J; Wu W; Zhang C; Xu Q; Tu K; Liu J
    Cell Death Dis; 2020 Sep; 11(9):730. PubMed ID: 32908135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells.
    Li M; Jin R; Wang W; Zhang T; Sang J; Li N; Han Q; Zhao W; Li C; Liu Z
    Oncotarget; 2017 Apr; 8(15):24777-24784. PubMed ID: 28445971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZEB1 enhances Warburg effect to facilitate tumorigenesis and metastasis of HCC by transcriptionally activating PFKM.
    Zhou Y; Lin F; Wan T; Chen A; Wang H; Jiang B; Zhao W; Liao S; Wang S; Li G; Xu Z; Wang J; Zhang J; Ma H; Lin D; Li Q
    Theranostics; 2021; 11(12):5926-5938. PubMed ID: 33897890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen Receptor Stimulates Hexokinase 2 and Induces Glycolysis by PKA/CREB Signaling in Hepatocellular Carcinoma.
    Sun RF; Zhao CY; Chen S; Yu W; Zhou MM; Gao CR
    Dig Dis Sci; 2021 Mar; 66(3):802-813. PubMed ID: 32274668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway.
    Wu H; Pan L; Gao C; Xu H; Li Y; Zhang L; Ma L; Meng L; Sun X; Qin H
    Molecules; 2019 May; 24(10):. PubMed ID: 31137633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
    Chen S; Wang L; Yao B; Liu Q; Guo C
    Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
    Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC01419 promotes cell proliferation and metastasis in hepatocellular carcinoma by enhancing NDRG1 promoter activity.
    Dang H; Chen L; Tang P; Cai X; Zhang W; Zhang R; Huang A; Tang H
    Cell Oncol (Dordr); 2020 Oct; 43(5):931-947. PubMed ID: 32557341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin enhances hepatocellular carcinoma cell metabolism, migration, and invasion in vitro via a hexokinase 2-dependent mechanism.
    Chai F; Li Y; Liu K; Li Q; Sun H
    J Cell Physiol; 2019 Feb; 234(2):1937-1946. PubMed ID: 30144070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma.
    Fan P; Wang B; Meng Z; Zhao J; Jin X
    Int J Biochem Cell Biol; 2018 Nov; 104():1-8. PubMed ID: 30172011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ribosomal RNA processing 15 Homolog (RRP15), which is overexpressed in hepatocellular carcinoma, suppresses tumour growth via induction of senescence and apoptosis.
    Zhao D; Qian L; Zhuang D; Wang L; Cao Y; Zhou F; Zhang S; Liu Y; Liang Y; Zhang W; Kang W; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Xu G; Lv Y; Zou X; Zhuge Y; Zhang B
    Cancer Lett; 2021 Oct; 519():315-327. PubMed ID: 34343634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Hua S; Lei L; Deng L; Weng X; Liu C; Qi X; Wang S; Zhang D; Zou X; Cao C; Liu L; Wu D
    Oncogene; 2018 Mar; 37(12):1624-1636. PubMed ID: 29335523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
    Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
    Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma.
    Jin F; Wang Y; Zhu Y; Li S; Liu Y; Chen C; Wang X; Zen K; Li L
    Sci Rep; 2017 Jun; 7(1):3089. PubMed ID: 28596599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerobic glycolysis enhances HBx-initiated hepatocellular carcinogenesis via NF-κBp65/HK2 signalling.
    Chen L; Lin X; Lei Y; Xu X; Zhou Q; Chen Y; Liu H; Jiang J; Yang Y; Zheng F; Wu B
    J Exp Clin Cancer Res; 2022 Nov; 41(1):329. PubMed ID: 36411480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.